A new study published in the Annals of Internal Medicine has added to the growing body of evidence that exposure to aluminum-adjuvanted childhood vaccines does not increase the risk of autoimmune, atopic or allergic disorders, or neurodevelopmental conditions such as autism.
The study, which analyzed data from over 1.2 million Danish children born between 1997 and 2018, found no association between cumulative aluminum exposure in vaccines and increased risk of any of 50 chronic conditions. The researchers used registry data on childhood vaccinations, aluminum content, outcomes, and potential confounding factors to investigate the potential link.
Only about 1.2% of children received no aluminum-containing vaccines before age 2, with each dose containing between 0.125 and 1.00 milligram of aluminum. The study found that even high levels of exposure were not associated with an increased risk of chronic conditions.
The study’s authors noted that while immunization with aluminum-adsorbed vaccines has been widely used for decades and is generally considered safe, concerns about potential harms continue to resurface. However, the findings of this study provide further reassurance that childhood vaccinations are not linked to neurodevelopmental disorders.
Key statistics include:
* 1.2% of children received no aluminum-adjuvanted vaccines before age 2
* Each dose contained between 0.125 and 1.00 milligram of aluminum
* High levels of exposure were not associated with an increased risk of chronic conditions
Overall, the study’s results support the safety of childhood vaccinations and provide further evidence against a link between aluminum-adjuvanted vaccines and neurodevelopmental disorders.
Source: https://www.cidrap.umn.edu/childhood-vaccines/report-no-link-between-aluminum-adjuvanted-childhood-vaccines-conditions-such